Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −2 vs. Q1 2023
- Shares held
- 20.7M
- −1.02M (−4.7%) vs. Q1 2023
- Total value
- $59.0M
- −$26.6M (−31.1%) vs. Q1 2023
- New holders
- 4
- 20 more added
- Sold out
- 6
- 12 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ICA Group Wealth Management, LLC | 100 | $285 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 172 | $490 | 0.00% | +73+73.7% | Added |
| UBS Group AG | 3,337 | $9.51K | 0.00% | +565+20.4% | Added |
| Simplex Trading, LLC | 3,588 | $10.0K | 0.00% | +3,588 | New |
| National Bank of Canada | 3,850 | $11.0K | 0.00% | +3,750+3,750.0% | Added |
| Federation des caisses Desjardins du Quebec | 10,500 | $29.9K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 10,810 | $30.8K | 0.00% | +8,659+402.6% | Added |
| Advisor Group Holdings, Inc. | 11,113 | $31.7K | 0.00% | +1,016+10.1% | Added |
| Virtu Financial LLC | 11,743 | $33.0K | 0.00% | +11,743 | New |
| Cubist Systematic Strategies, LLC | 12,957 | $36.9K | 0.00% | +4,037+45.3% | Added |
| Creative Planning | 13,080 | $37.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 13,676 | $39.0K | 0.00% | −93,813−87.3% | Reduced |
| Beta Wealth Group, Inc. | 14,127 | $40.3K | 0.02% | +14,127 | New |
| PVG Asset Management Corp | 15,405 | $43.9K | 0.19% | −430−2.7% | Reduced |
| Geode Capital Management, LLC | 17,576 | $50.1K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 18,056 | $51.5K | 0.00% | +1,626+9.9% | Added |
| State Street Corp | 21,611 | $61.6K | 0.00% | −388−1.8% | Reduced |
| Susquehanna International Group, LLP | 23,261 | $66.3K | 0.00% | +10,875+87.8% | Added |
| Boothbay Fund Management, LLC | 25,176 | $71.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,700 | $73.2K | 0.00% | +11,400+79.7% | Added |
| HighTower Advisors, LLC | 31,000 | $88.0K | 0.00% | +4,800+18.3% | Added |
| Clear Creek Financial Management, LLC | 31,929 | $91.0K | 0.02% | −4,000−11.1% | Reduced |
| LMR Partners LLP | 38,495 | $109.7K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 45,694 | $130.2K | 0.00% | +45,694 | New |
| Two Sigma Investments, LP | 52,186 | $148.7K | 0.00% | +16,879+47.8% | Added |
| Gsa Capital Partners LLP | 66,340 | $189.0K | 0.02% | −33,428−33.5% | Reduced |
| Renaissance Technologies LLC | 108,766 | $310.0K | 0.00% | +16,966+18.5% | Added |
| Valeo Financial Advisors, LLC | 118,699 | $338.3K | 0.02% | +5,000+4.4% | Added |
| Marshall Wace, LLP | 167,101 | $476.2K | 0.00% | −65,391−28.1% | Reduced |
| Dimensional Fund Advisors LP | 179,987 | $513.0K | 0.00% | −3,257−1.8% | Reduced |
| BIT Capital GmbH | 207,276 | $590.7K | 0.07% | +9,000+4.5% | Added |
| Point72 Asset Management, L.P. | 232,659 | $663.1K | 0.00% | −1,042,341−81.8% | Reduced |
| JPMorgan Chase & Co | 247,163 | $704.4K | 0.00% | −128,891−34.3% | Reduced |
| BML Capital Management, LLC | 272,500 | $776.6K | 0.70% | +52,500+23.9% | Added |
| Affinity Asset Advisors, LLC | 300,068 | $855.2K | 0.34% | +100,686+50.5% | Added |
| Lion Point Capital, LP | 450,207 | $1.28M | 0.95% | +25,000+5.9% | Added |
| Ikarian Capital, LLC | 460,416 | $1.31M | 0.46% | 00.0% | Unchanged |
| Citadel Advisors LLC | 469,750 | $1.34M | 0.00% | −339,743−42.0% | Reduced |
| Boxer Capital, LLC | 698,861 | $1.99M | 0.09% | 00.0% | Unchanged |
| Barclays PLC | 800,776 | $2.28M | 0.00% | −46,052−5.4% | Reduced |
| Morgan Stanley | 805,039 | $2.29M | 0.00% | −32,816−3.9% | Reduced |
| Alta Fundamental Advisers LLC | 897,961 | $2.56M | 1.41% | 00.0% | Unchanged |
| Bleichroeder LP | 1,326,085 | $3.78M | 0.77% | 00.0% | Unchanged |
| Millennium Management LLC | 1,751,168 | $4.99M | 0.01% | +22,146+1.3% | Added |
| VR Adviser, LLC | 2,208,812 | $6.30M | 1.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,555,287 | $7.28M | 0.00% | +2,822+0.1% | Added |
| BlackRock Inc. | 2,651,200 | $7.56M | 0.00% | +576,842+27.8% | Added |
| RTW Investments, LP | 3,256,102 | $9.28M | 0.18% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −146,806−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,636−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,513−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,460−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |